Acrobiosystems Co (SZSE:301080) FCF Margin % : 18.69% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Acrobiosystems Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Acrobiosystems Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥27.3 Mil. Acrobiosystems Co's Revenue for the three months ended in Mar. 2024 was ¥146.0 Mil. Therefore, Acrobiosystems Co's FCF Margin % for the quarter that ended in Mar. 2024 was 18.69%.

As of today, Acrobiosystems Co's current FCF Yield % is -0.37%.

The historical rank and industry rank for Acrobiosystems Co's FCF Margin % or its related term are showing as below:

SZSE:301080' s FCF Margin % Range Over the Past 10 Years
Min: -25.17 Med: -3.22 Max: 33.09
Current: -3.13

During the past 7 years, the highest FCF Margin % of Acrobiosystems Co was 33.09%. The lowest was -25.17%. And the median was -3.22%.

SZSE:301080's FCF Margin % is ranked better than
76.83% of 1040 companies
in the Biotechnology industry
Industry Median: -139.2 vs SZSE:301080: -3.13

Acrobiosystems Co FCF Margin % Historical Data

The historical data trend for Acrobiosystems Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrobiosystems Co FCF Margin % Chart

Acrobiosystems Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

9.98

33.09

19.83

-17.30

-3.22

Acrobiosystems Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															19.80	-15.19	-14.37	-2.97	18.69

Competitive Comparison of Acrobiosystems Co's FCF Margin %

For the Biotechnology subindustry, Acrobiosystems Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acrobiosystems Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrobiosystems Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Acrobiosystems Co's FCF Margin % falls into.

Acrobiosystems Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Acrobiosystems Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-17.49	/	543.653
	=	-3.22 %

Acrobiosystems Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	27.283	/	145.999
	=	18.69 %

Acrobiosystems Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Acrobiosystems Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Acrobiosystems Co (SZSE:301080) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrobiosystems Co Ltd (SZSE:301080) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Hongda North Road, 4th Floor, Building 4, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176

Website

https://www.acrobiosystems.cn

Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Acrobiosystems Co (SZSE:301080) Headlines

No Headlines